| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
64,210,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
141 |
Avg
Vol: |
1,513,129 |
| 52
Week Range: |
$0.000001 - $0.238 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Infinity Pharmaceuticals is a clinical-stage biopharmaceutical company. Co. is focused on advancing eganelisib (IPI-549), an orally administered, clinical-stage, immuno-oncology product candidate that reprograms macrophages through selective inhibition of the enzyme phosphoinositide-3-kinase-gamma. The preclinical findings indicate that eganelisib may have the potential to treat various solid tumors and represents an additive or synergistic approach to restoring anti-tumor immunity in combination with other immunotherapies such as checkpoint inhibitors. Further, preclinical studies showed that eganelisib inhibits the regrowth of tumors that can occur following treatment with chemotherapy.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
410,196 |
425,190 |
| Total Sell Value |
$0 |
$0 |
$28,714 |
$38,646 |
| Total People Sold |
0 |
0 |
1 |
2 |
| Total Sell Transactions |
0 |
0 |
1 |
2 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lillig John |
Chief Technology Officer |
• – – |
2004-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
46,000 |
|
- |
|
| Kussman Craig |
Chief Financial Officer |
• – – |
2004-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
85,000 |
|
- |
|
| Crouch Taylor |
President & COO |
• – – |
2004-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
85,000 |
|
- |
|
| Livingston Douglas A |
SVP Chemistry |
• – – |
2004-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
|
- |
|
| Pigliucci Riccardo |
Chairman & CEO |
• • – |
2004-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
791,507 |
|
- |
|
| Neale Richard |
Vice President |
• – – |
2004-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
37,418 |
|
- |
|
| Lillig John |
Chief Technology Officer |
• – – |
2004-01-15 |
4 |
D |
$6.10 |
$13,728 |
D/D |
(2,250) |
7,000 |
|
- |
|
| Lillig John |
Chief Technology Officer |
• – – |
2004-01-02 |
4 |
D |
$5.70 |
$32,499 |
D/D |
(5,600) |
9,250 |
|
- |
|
| Lillig John |
Chief Technology Officer |
• – – |
2004-01-02 |
4 |
D |
$5.86 |
$2,344 |
D/D |
(400) |
9,250 |
|
- |
|
| Lillig John |
Chief Technology Officer |
• – – |
2003-12-18 |
4 |
D |
$5.50 |
$27,500 |
D/D |
(5,000) |
15,250 |
|
- |
|
| Lillig John |
Chief Technology Officer |
• – – |
2003-12-04 |
4 |
D |
$5.25 |
$26,378 |
D/D |
(5,000) |
20,250 |
|
- |
|
| Lillig John |
Chief Technology Officer |
• – – |
2003-11-20 |
4 |
D |
$5.70 |
$34,200 |
D/D |
(6,000) |
25,250 |
|
- |
|
| Lillig John |
Chief Technology Officer |
• – – |
2003-11-06 |
4 |
D |
$5.80 |
$29,679 |
D/D |
(5,000) |
31,250 |
|
- |
|
| Lillig John |
Chief Technology Officer |
• – – |
2003-10-23 |
4 |
D |
$5.80 |
$29,000 |
D/D |
(5,000) |
36,250 |
|
- |
|
| Lillig John |
Chief Technology Officer |
• – – |
2003-10-09 |
4 |
D |
$5.31 |
$26,648 |
D/D |
(5,000) |
41,250 |
|
- |
|
| Lillig John |
Chief Technology Officer |
• – – |
2003-09-25 |
4 |
D |
$5.86 |
$29,445 |
D/D |
(5,000) |
46,250 |
|
- |
|
| Lillig John |
Chief Technology Officer |
• – – |
2003-09-11 |
4 |
D |
$5.17 |
$20,680 |
D/D |
(4,000) |
51,250 |
|
- |
|
| Lillig John |
Chief Technology Officer |
• – – |
2003-08-28 |
4 |
D |
$4.77 |
$14,310 |
D/D |
(3,000) |
55,250 |
|
- |
|
| Lillig John |
Chief Technology Officer |
• – – |
2003-08-14 |
4 |
D |
$4.88 |
$19,552 |
D/D |
(4,000) |
58,250 |
|
- |
|
| Kussman Craig |
Chief Financial Officer |
• – – |
2003-08-04 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
0 |
|
- |
|
| Pigliucci Riccardo |
Chief Executive Officer |
• • – |
2003-08-04 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
616,507 |
|
- |
|
| Crouch Taylor |
Chief Operating Officer |
• – – |
2003-08-04 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
0 |
|
- |
|
| Lillig John |
Chief Technology Officer |
• – – |
2003-08-04 |
4 |
A |
$0.00 |
$0 |
D/D |
13,000 |
60,250 |
|
- |
|
| Neale Richard |
officerTitle |
• – – |
2003-08-04 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
11,542 |
|
- |
|
| Regenass Urs |
officerTitle |
• – – |
2003-08-04 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
0 |
|
- |
|
227 Records found
|
|
Page 9 of 10 |
|
|
